ICCC
ImmuCell Corporation
9.90$
-0.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.7% | -1.7% | -2.8% | +6.2% | +1.5% | +1.2% | +2.4% | -2.1% | -7.0% | +3.7% | +5.7% | |
| – | -91.8% | +1,059.1% | -4.9% | +28.7% | +8.3% | +5.8% | +7.6% | -1.8% | +0.7% | +11.3% | +11.8% | |
| – | -50.8% | -1.9% | +37.9% | +187.6% | -1.3% | +22.4% | +30.4% | -35.2% | -2.0% | +79.0% | +30.1% | |
| – | -50.8% | -1.9% | +37.9% | +187.6% | -1.3% | +22.4% | +30.4% | -35.2% | -2.0% | +79.0% | +30.1% | |
| – | – | – | -24.7% | +18.6% | +62.8% | -10.7% | -28.8% | +7.6% | +31.0% | -21.2% | +7.5% | |
| – | – | – | +2.1% | +2.2% | -4.7% | +3.4% | +12.7% | +18.2% | -5.5% | -6.4% | +4.7% | |
| – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | -14.3% | -16.7% | -20.0% | -25.0% | -33.3% | -50.0% | – | – | – | |
| – | – | – | -0.1% | -2.0% | -2.5% | -5.4% | +1.4% | -5.5% | -2.8% | -3.3% | +1.9% | |
| – | – | – | +8.9% | -2.0% | -1.2% | -12.4% | +15.0% | -10.1% | -0.5% | -1.6% | +13.4% | |
| – | – | – | -2.3% | -1.7% | -1.6% | -1.7% | -2.1% | -9.9% | +1.3% | +1.3% | -5.2% | |
| – | – | – | -39.6% | +101.6% | +6.8% | +4.5% | +32.3% | -25.5% | -18.1% | +25.4% | +181.2% | |
| – | – | – | -3.6% | -3.8% | -4.1% | -4.3% | -4.5% | -4.4% | -5.2% | -5.5% | -3.9% | |
| – | – | – | -4.8% | +12.6% | +4.2% | +5.4% | +3.0% | -0.2% | -9.2% | +7.7% | +7.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.8% | +4.5% | +9.4% | +0.5% | +0.6% | +0.2% | +0.0% | 0.0% | +1.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.